Results 1 to 10 of about 26,281 (176)

Highlights on the Management of Oligometastatic Disease [PDF]

Journal of Immunotherapy and Precision Oncology, 2020
Purpose: The understanding of oligometastatic disease (OMD) is rapidly evolving and with this comes the ability to utilize a number of modalities that excel in the localized control of disease.
Salem M. Alshehri, Khaled Alkattan, Ahmed Abdelwarith, Hussain Alhussain, Shaker Shaker, Majed Alghamdi, Hossam Alassaf, Ali Albargawi, Manal Al Naimi, Ameen Alomair, Saif Althaqfi, Adnan Alhebshi, Majid Alothman, AbdulRahman Jazieh   +13 more
doaj   +1 more source

Prolonged overall treatment time negatively affects the outcomes of stereotactic body radiotherapy for early-stage non-small-cell lung cancer: A propensity score-weighted, single-center analysis.

PLoS ONE, 2021
Previous studies have reported conflicting results for the effect of overall treatment time with stereotactic body radiotherapy on tumor control in early-stage non-small-cell lung cancer.
Toshiki Ikawa, Takahiro Tabuchi, Koji Konishi, Masahiro Morimoto, Takero Hirata, Naoyuki Kanayama, Kentaro Wada, Masayasu Toratani, Sumiyo Okawa, Kazuhiko Ogawa, Teruki Teshima   +10 more
doaj   +1 more source

Chronic expanding hematoma of the left erector spinae muscle after stereotactic body radiotherapy for renal cell carcinoma: a case report

Journal of Medical Case Reports, 2022
Background Hematomas that slowly increase in size for more than 1 month after the initial hemorrhage are referred to as chronic expanding hematomas. Chronic expanding hematoma can also occur after radiosurgery; however, there have been no reports about ...
Yojiro Ishikawa, Takaya Yamamoto, Rei Umezawa, Noriyoshi Takahashi, Kazuya Takeda, Yu Suzuki, Keiichi Jingu   +6 more
doaj   +1 more source

Serious gastric perforation after second stereotactic body radiotherapy for peripheral lung cancer that recurred after initial stereotactic body radiotherapy: a case report

Journal of Medical Case Reports, 2017
Background In recent reports, re-irradiation with stereotactic body radiotherapy for lung tumors in patients previously treated with thoracic radiation therapy resulted in several serious toxicities.
Hotaka Nonaka, Hiroshi Onishi, Masatoki Ozaki, Kengo Kuriyama, Takafumi Komiyama, Ryo Saito   +5 more
doaj   +1 more source

Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT) Cost-Effectiveness Results

Frontiers in Oncology, 2013
Objective: To describe and synthesize the current stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) cost-effectiveness research to date across several common SRS and SBRT applications.
Akash eBijlani, Giovanni eAguzzi, David eSchaal, Pantaleo eRomanelli   +3 more
doaj   +1 more source

An optimal dose‐fractionation for stereotactic body radiotherapy in peripherally, centrally and ultracentrally located early‐stage non‐small lung cancer

Thoracic Cancer, 2023
Stereotactic body radiotherapy (SBRT), also known as stereotactic ablative radiotherapy (SABR), is commonly used in inoperable patients with early‐stage non‐small lung cancer (NSCLC).
Izabela Zarębska, Maciej Harat
doaj   +1 more source

A first report of tumour-tracking radiotherapy with helical tomotherapy for lung and liver tumours: A double case report

SAGE Open Medical Case Reports, 2021
There are only a limited number of previous reports on clinical cases using tumour tracking with tomotherapy. Therefore, we present two cases of patients treated with tumour tracking with tomotherapy.
Wataru Okada, Hiroshi Doi, Masao Tanooka, Keisuke Sano, Kenji Nakamura, Yusuke Sakai, Mayuri Shibata, Masahiro Tanaka   +7 more
doaj   +1 more source

Stereotactic Ablative Body Radiotherapy (SABR) in The Management Spinal Metastases: A Brief Overview*

Indonesian Journal of Cancer, 2017
It is well known that radiotherapy provides successful pain relief in bone metastases. Advancements in imaging and radiotherapy delivery technology have enabled safe delivery of higher dose radiotherapy, which will produce more durable tumor control ...
HENRY KODRAT, SOEHARTATI GONDHOWIARDJO
doaj   +1 more source

Is there a role for stereotactic radiotherapy in the treatment of renal cell carcinoma?

Clinical and Translational Radiation Oncology, 2019
Renal cell carcinoma (RCC) has traditionally been regarded as radioresistant tumor based on preclinical data and negative clinical trials using conventional fractionated radiotherapy. However, there is emerging evidence that radiotherapy delivered in few
Alexander Rühle, Nicolaus Andratschke, Shankar Siva, Matthias Guckenberger   +3 more
doaj   +1 more source

NRG Oncology Survey on Practice and Technology Use in SRT and SBRT Delivery

Frontiers in Oncology, 2020
PurposeTo assess stereotactic radiotherapy (SRT)/stereotactic body radiotherapy (SBRT) practices by polling clinics participating in multi-institutional clinical trials.MethodsThe NRG Oncology Medical Physics Subcommittee distributed a survey consisting ...
Mikhail Chetvertkov, James Ira Monroe, Jaskaran Boparai, Timothy D. Solberg, Deanna H. Pafundi, Russell L. Ruo, David J. Gladstone, Fang-Fang Yin, Indrin J. Chetty, Stanley Benedict, David S. Followill, Ying Xiao, Jason W. Sohn   +12 more
doaj   +1 more source